Description
MODIFICATION TO DECREASE EXCESS FUNDS.
Base award description: IGF::OT::IGF LAB TESTING FOR BREAST AND COLON CANCER
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-04-17+$48,000= $48,000
- Mod P000012018-12-27+$47,718= $95,718
- Mod P000022019-10-13-$27,856= $67,862
- Mod P000032019-12-20+$47,718= $115,581
- Mod P000042020-11-30-$26,994= $88,586
- Mod P000052020-12-22+$47,718= $136,304
- Mod P000062021-08-11-$23,541= $112,764
- Mod P000072021-12-10+$23,859= $136,623
- Mod P000082022-10-27-$37,038= $99,585
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-04-17 | +$48,000 | $48,000 | IGF::OT::IGF LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00001· EXERCISE AN OPTION | 2018-12-27 | +$47,718 | $95,718 | IGF::OT::IGF LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2019-10-13 | −$27,856 | $67,862 | LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00003· EXERCISE AN OPTION | 2019-12-20 | +$47,718 | $115,581 | LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2020-11-30 | −$26,994 | $88,586 | LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00005· EXERCISE AN OPTION | 2020-12-22 | +$47,718 | $136,304 | LAB TESTING FOR BREAST AND COLON CANCER |
| Mod P00006· FUNDING ONLY ACTION | 2021-08-11 | −$23,541 | $112,764 | MODIFICATION TO DECREASE EXCESS FUNDS. |
| Mod P00007· EXERCISE AN OPTION | 2021-12-10 | +$23,859 | $136,623 | MODIFICATION TO DECREASE EXCESS FUNDS. |
| Mod P00008· FUNDING ONLY ACTION | 2022-10-27 | −$37,038 | $99,585 | MODIFICATION TO DECREASE EXCESS FUNDS. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26026N0312 | SLEEP CARE, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $68,520 | FY2026 |
| 36C26026P0708 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $19,500 | FY2026 |
| 36C26026N0421 | BLOODWORKS | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $40,000 | FY2026 |
| 36C26026P0562 | UNIVERSITY OF CALIFORNIA, DAVIS | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $1,024 | FY2026 |
| 36C26026N0382 | DIASORIN INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $125,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018F1885_3600_V797D70053_3600 · retrieved 2026-09-26.